Inflammation is a risk factor for venous thromboembolism. We have investigated wheter a certain infammatory marker is associated with future venous thromboembolism.
Hospitalization is a well-known risk factor for venous thrombosis, but the risk of recurrence after hospital-related incidents is uncertain. Recently, we at K.G. Jebsen TREC may have shed some light on this matter.
Does variation in the size of the red blood cells cause increased formation of atherosclerotic plaques?
A recent study from K.G. Jebsen TREC shows an association between the size variation of the red blood cells, and increased progression of atherosclerosis.
Findings from K. G. Jebsen TREC suggests that high red blood cell distribution width (RDW) is a risk factor of Venous thromboembolism (VTE), and that RDW is a predictor of all-cause mortality in VTE-patients.
TREC findings suggest that the pattern of body fat distribution and the metabolic changes in obesity have differential impact on the risk of venous and arterial thrombosis
Results from a recent study suggest that compression stockings do not provide pain relief
after a deep vein thrombosis
Is the risk of venous thromboembolism in carriers of a prothrombin mutation influenced by high levels of microparticles?
Venous thromboembolism (VTE) is a complex disorder where several risk factors, including environmental, lifestyle, and genetic factors, play a part. Prothrombin gene mutation (PTM) is one of the most common genetic polymorphisms known to predispose carriers to VTE. PTM is found in 5% to 10% of patients with VTE. PTM results in an increased level of prothrombin in the blood and prothrombin plays a key role in the clotting cascade.
My name is Huang Chi Wei. I am a fourth year medical student from Taiwan. I came to Tromsø and K.G. Jebsen TREC for one month as an exchange student to get basic lab experience.
High fish consumption is known to reduce the risk of arterial cardiovascular
diseases such as myocardial infarction.
Recent studies have demonstrated an association between arterial and venous thrombosis. Whether carotid atherosclerosis, a risk factor for myocardial infarction (MI), is associated with venous thrombosis (VTE) is unclear.
A venous thrombotic event increases the risk of death and morbidity in cancer patients, and can delay active cancer treatment. Medical prophylaxis reduces the incidence of venous thrombosis in ambulatory cancer patients and is therefore recommended to ambulatory cancer patients with high risk of venous thrombosis.
Venous thrombosis patients with persistently negative D-dimer tests after cessation of standard therapy have a low recurrence risk and can stop anticoagulation. A study conducted by Italian scientists show that a management procedure based on repeated D-dimer testing can be used to identify those with a low risk of recurrence in whom anticoagulation can be discontinued.
Family history of myocardial infarction share yet unknown inherited or environmental risk factors of venous thrombosis
Commercial airline pilots are occupationally exposed to factors that may influence health negatively, but the incidence of VTE in commercial air line pilots has not previously been examined in a prospective setting
Growing evidence supports an association between venous thromboembolism (VTE) and arterial thrombotic diseases (i.e. myocardial infarction and ischemic stroke).